Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
Humana (NYSE: HUM) will release its first-quarter 2026 (1Q26) financial results and prepared management remarks at 6:00 a.m. ET on April 29, 2026. A live Q&A session will follow at 8:00 a.m. ET the same day to discuss results and 2026 earnings guidance.
A webcast and archived presentation will be available on Humana’s Investor Relations page, and the news release will include reconciliations of non-GAAP to GAAP measures.
Humana (NYSE:HUM) and Yale researchers report a sharp rise in continuous glucose monitor (CGM) use among Medicare Advantage members with type 2 diabetes from January 2021 to December 2023. The share of insulin-using members on CGMs grew from under 2% to about 16.7% (roughly 1 in 6).
The study found CGM users often had more complex health profiles, endocrinology visits increased CGM use (>4x likelihood), and the oldest and least-engaged patients were less likely to use CGMs. Humana notes most Medicare Advantage members will have no out-of-pocket cost for CGMs in 2026.
Humana (NYSE: HUM) completed a public offering of $1.0 billion aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056 at an annual rate of 6.625%. The company expects net proceeds of approximately $986 million after underwriting discounts and estimated offering expenses.
The company intends to use net proceeds for general corporate purposes, which may include repaying existing indebtedness, including borrowings under its commercial paper program.
Humana (NYSE: HUM) issued $1.0 billion of 6.625% fixed-rate junior subordinated notes due 2056, receiving an AM Best long-term issue credit rating of bbb- with a stable outlook.
AM Best expects the issuance to raise AM Best–measured financial leverage to about 41.8%, modestly above Humana's long-term 40% target, and noted solid but reduced liquidity and EBIT interest coverage of 4–8x.
Humana (NYSE: HUM) priced a public offering of $1.0 billion aggregate principal of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000% of principal. The offering is expected to close on March 9, 2026 and net proceeds are estimated at approximately $986 million.
The company intends to use net proceeds for general corporate purposes, which may include repayment of existing indebtedness and commercial paper borrowings. Joint book-running managers include Goldman Sachs, J.P. Morgan, Mizuho, Truist and Wells Fargo.
Humana (NYSE:HUM) announced on March 3, 2026 new value-based cardiology partnerships to expand cardiac care for eligible Medicare Advantage members.
New agreements with Karoo Health, US Heart and Vascular, Chamber Cardio and expanded Novocardia services add remote monitoring, 24/7 hotlines, integrated care teams and localized value-based care across multiple states.
Humana Foundation (NYSE:HUM) expanded its support for Face the Fight®, committing $5 million to scale suicide-prevention programs, strengthen data collection, and expand community supports for veterans. This builds on an earlier three-year, $6 million commitment and coincides with the coalition’s second annual meeting, March 3–4, 2026, in Louisville, Ky.
The coalition updated a 2026–2028 Strategic Plan and set an aspirational goal to save 15,000 veteran lives by 2032.
Humana (NYSE:HUM) said CEO Jim Rechtin and CFO Celeste Mellet will present at the Leerink Partners Global Healthcare Conference on March 10, 2026 at 10:40 a.m. ET. A live audio webcast will be available on Humana’s Investor Relations page.
The company recommends signing on about 15 minutes early to complete a system test and download any required free software for access.
Humana (NYSE: HUM) announced a quarterly cash dividend of $0.885 per share, payable April 24, 2026 to shareholders of record at the close of business on March 27, 2026.
This dividend reinforces Humana's return of capital to shareholders and provides a specific timeline for eligibility and payment.
Humana (NYSE: HUM) is investing more than $1.7 million in Illinois to support housing stability, workforce development, maternal and behavioral health, and to reduce disparities. 2026 grants fund community partners including Brightpoint, Illinois Public Health Association, Illinois Rural Health Association, SIU School of Medicine, NAMI Illinois, and SIHF Healthcare, building on a total commitment exceeding $3 million to address health-related social needs statewide.